Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine whether adjunctive galantamine is effective in the
treatment of cognitive impairments in patients with schizophrenia.
Phase:
Phase 4
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore
Collaborators:
Ortho-McNeil Neurologics, Inc. Stanley Medical Research Institute